Other
2029
Medtronic 2029 increased by 0.1% to $1.48B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 6.0%, from $1.57B to $1.48B. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryProfitability
SignalLower is better
VolatilityStable
First reportedQ3 2016
Last reportedQ3 2026Feb 24, 2026
How to read this metric
Consistent projections allow for better predictability of future earnings and non-cash charges.
Detailed definition
This represents the projected amortization expense for finite-lived intangible assets for the year 2029. It is a forward...
Peer comparison
Standard disclosure for banks with significant historical acquisition activity.
Metric ID:
other_finite_lived_intangible_assets_amortization_expens_a9462eHistorical Data
15 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.60B | $1.61B | $1.61B | $1.61B | $1.61B | $1.62B | $1.62B | $1.62B | $1.63B | $1.55B | $1.57B | $1.57B | $1.48B | $1.48B | $1.48B |
| QoQ Change | — | +0.6% | -0.1% | +0.4% | +0.1% | +0.2% | +0.1% | +0.3% | +0.3% | -4.7% | +0.8% | +0.6% | -6.2% | +0.1% | +0.1% |
| YoY Change | — | — | — | +1.0% | +0.4% | +0.7% | +0.4% | +0.6% | +0.7% | -4.1% | -3.6% | -3.4% | -4.8% | -5.6% | -6.0% |
Range$1.48B – $1.63B
CAGR-2.2%
Avg YoY Growth-2.0%
Median YoY Growth-1.5%
Current Streak2 quarters growth
2029 at Other Companies
Frequently Asked Questions
- What is Medtronic's 2029?
- Medtronic (MDT) reported 2029 of $1.48B in Q4 2025.
- How has Medtronic's 2029 changed year-over-year?
- Medtronic's 2029 decreased by 6.0% year-over-year, from $1.57B to $1.48B.
- What does 2029 mean?
- The expected non-cash expense for acquired intangible assets in the year 2029.